18 completed, 12 unknown, 6 not yet recruiting, 3 recruiting. 43 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 43 | Completed 18, Unknown 12, Not yet recruiting 6, Recruiting 3, Terminated 2, Withdrawn 2 |
Follow Hypotrichosis: new trials by email Literature Review of Hypotrichosis trials Research Report on Hypotrichosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Topical Calcipotriol and Intralesional Steroids in Alopecia Areata Calcipotriol, Triamcinolone Acetonide - Alopecia Areata | Phase 4 | Not yet recruiting | Hayat Abad Medical Complex, Peshawar | 60 | 2026-10-01 | 2026-09-21 |
| The Effect of Nanofat Injection on Androgenetic Alopecia Minoxidil 5 %, PRP injection, Nanofat injection - Androgenetic Alopecia, Androgenetic Alopecia (AGA) | Phase 4 | Not yet recruiting | Assiut University | 60 | 2026-04-01 | 2026-04-13 |
| Topical Methotrexate vs Minoxidil for Localized Alopecia Areata Methotrexate 1% Topical Gel, Minoxidil 5% Topical Spray - Alopecia Areata | Phase 4 | Not yet recruiting | Jinnah Postgraduate Medical Centre | 268 | 2026-03-15 | 2026-03-10 |
| Tofacitinib vs Methotrexate for Severe Alopecia Areata (TOFA-MTX-AA) Tofacitinib, Methotrexate - Alopecia Areata, Alopecia Totalis (AT) | Phase 4 | Not yet recruiting | Hayat Abad Medical Complex, Peshawar | 78 | 2026-02-15 | 2026-02-12 |
| Comparative Effectiveness of Intralesional Injection of Triamcinolone Acetonide vs. Microneedling With Local Application of Triamcinolone Acetonide in the Treatment of Alopecia Areata Triamcinolone acetonide, Microneedling with topical triamcinolone acetonide - Alopecia Areata | Phase 4 | Recruiting | Dow University of Health Sciences | 276 | 2026-01-01 | 2026-11-09 |
| Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness Study Methotrexate, Cyclosporin (CSA) - Alopecia Areata(AA), Alopecia Areata (AA) | Phase 4 | Recruiting | Erasmus Medical Center | 50 | 2025-11-01 | 2026-02-02 |
| Effect of Platelet-Rich Plasma Versus Placebo in the Treatment of Central Centrifugal Cicatricial Alopecia Platelet-Rich Plasma (PRP) Injections, Saline - Central Centrifugal Cicatricial Alopecia | Phase 4 | Not yet recruiting | Baylor College of Medicine | 56 | 2025-09-30 | 2025-09-24 |
| Efficacy and Safety of Dallixa® Eyelash Serum in Idiopathic Eyelash Hypotrichosis dermo cosmetic product - Hypotrichosis | Phase 4 | Completed | Quantum Aesthetics Cosmetics | 37 | 2025-08-28 | 2026-11-06 |
| Evaluation of the Efficacy and Safety of Oral Roflumilast Versus Intralesional Corticosteroids Injection (ILCs) in the Treatment of Alopecia Areata Roflumilast, intralesional steroid - Alopecia, Alopecia Areata | Phase 4 | Completed | Cairo University | 50 | 2025-01-12 | 2025-09-15 |
| Topical Simvastatin Versus Topical Steroid in Treatment of Alopecia Areata Simvastatin, Mometasone Furoate, Fractional CO2 laser - Alopecia Areata | Phase 4 | Not yet recruiting | Assiut University | 54 | 2024-10-01 | 2024-05-06 |
| Efficacy/ Safety of DNN.22.17.036 in Male Patients With Pattern Hair Loss DNN.22.17.036, 10573048700 - Alopecia | Phase 4 | Unknown | Ache Laboratorios Farmaceuticos S.A. | 196 | 2024-04-01 | 2024-04-10 |
| MALE HAIR LOSS - Treatment With Dutasteride Mesotherapy x Dutasteride MMP Technique (Injections With Tattoo Machine) MESOTHERAPY (INJECTIONS WITH SYRINGE AND NEEDLE), MMP (INJECTIONS WITH A TATTOO MACHINE) - Androgenic Alopecia | Phase 4 | Unknown | Clinica Dermatologica Arbache ltda | 60 | 2023-10-30 | 2023-11-01 |
| Effectiveness and Safety of Platelet-rich Plasma and Topical 5% Minoxidil Combination in Male Androgenetic Alopecia Platelet-Rich Plasma and Topical 5% Minoxidil, Topical 5% Minoxidil - Androgenetic Alopecia | Phase 4 | Unknown | Universitas Indonesia | 36 | 2023-06-01 | 2023-09-21 |
| Efficacy of Oral Apremilast in the Treatment of Alopecia Areata at the Tertiary Care Hospital, Karachi. Apremilast 30mg - Alopecia Areata | Phase 4 | Completed | Jinnah Postgraduate Medical Centre | 30 | 2022-08-01 | 2023-07-03 |
| Needle-free Delivery of Intralesional Triamcinolone for Pediatric Alopecia Areata MedJet Device with intralesional triamcinolone - Alopecia Areata | Phase 4 | Terminated | University Hospitals Cleveland Medical Center | 3 | 2022-03-24 | 2024-01-31 |
| Hydraderm for Androgenic Alopecia Venus Glow - Androgenic Alopecia | Phase 4 | Withdrawn | University of Minnesota | 2022-03-14 | 2025-01-27 | |
| Excimer Light and Topical Steroid in Treatment of Alopecia Areata topical steroid and 308nm-Excimer light therapy - Alopecia Areata | Phase 4 | Unknown | Assiut University | 30 | 2021-04-01 | 2021-03-11 |
| Topical Cetirizine 1% vs Minoxidil 5% Gel in Treatment of Androgenetic Alopecia Cetirizine, Minoxidil - Androgenetic Alopecia | Phase 4 | Unknown | Assiut University | 60 | 2020-06-01 | 2020-03-04 |
| Modified SALT Score for Alopecia Areata Triamcinolone Acetonide, saline - Alopecia Areata | Phase 4 | Unknown | Kasr El Aini Hospital | 20 | 2020-01-01 | 2020-06-02 |
| Comparative Study for Treatment of Alopecia Areata Using Carboxytherapy and Intralesional Steroids Carboxytherapy, Intralesional Steroid Injection - Alopecia Areata | Phase 4 | Unknown | Kasr El Aini Hospital | 30 | 2019-08-20 | 2020-01-14 |
Showing 20 of 43. Sign in to see all of them.
Alopecia Areata (25) · Alopecia (15) · Alopecia universalis (4) · Acne Vulgaris (1) · Cicatrix, Hypertrophic (1) · Dermoid Cyst (1) · Diffuse alopecia (1) · Granuloma Annulare (1) · Hair Diseases (1) · Keloid (1) · Keratoacanthoma (1) · Lichen Planus (1) · Lymphoma, Follicular (1) · Neurodermatitis (1)
Skin Diseases (43) · Skin and Connective Tissue Diseases (43) · Hair Diseases (42) · Alopecia (23) · Pathological Conditions, Signs and Symptoms (16) · Pathological Conditions, Anatomical (15) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Acneiform Eruptions (1) · Cicatrix (1) · Collagen Diseases (1) · Connective Tissue Diseases (1) · Cysts (1) · Dermatitis (1)
Triamcinolone Acetonide (8) · Minoxidil (7) · Bimatoprost (5) · Clobetasol (3) · Methotrexate (3) · Gels (2) · Injections (2) · Sodium Chloride (2) · Solutions (2) · tofacitinib (2) · Adrenal Cortex Hormones (1) · Capsaicin (1) · Cetirizine (1) · Cryotherapy (1) · Cyclosporine (1)
Assiut University (7) · Allergan (3) · Hordinsky, Maria K., MD (3) · Cairo University (2) · Hayat Abad Medical Complex, Peshawar (2) · Jinnah Postgraduate Medical Centre (2) · Kasr El Aini Hospital (2) · University of Minnesota (2) · ATS Clinical Research (1) · Ache Laboratorios Farmaceuticos S.A. (1) · Baylor College of Medicine (1) · Callender Center for Clinical Research (1) · Clinica Dermatologica Arbache ltda (1) · Columbia University (1) · Dow University of Health Sciences (1)
United States (18) · Egypt (10) · Brazil (2) · Pakistan (2) · India (1) · Indonesia (1) · Netherlands (1) · Saudi Arabia (1) · Thailand (1) · Turkey (Türkiye) (1)
Maria Hordinsky, MD (4) · Marna Ericson, Ph D (2) · Adhika A Lestari, MD (1) · Alaa Ghazally, MS (1) · Alaa H Ghazally, MD (1) · Amelia K Hausauer, MD (1) · Amy J McMichael, MD (1) · Ava Shamban, MD (1) · Brian Drolet, MD (1) · Cherie Young, M.D. (1) · Chinmanat Lekhavat, MD (1) · Christina L. Mitchell, M.D. (1) · Faiza Inam, FCPS (1)
PMID 20115945, PMID 20384750, PMID 20384751, PMID 22512484, PMID 22524397, PMID 24202232, PMID 25315746, PMID 26183987, PMID 28300084, PMID 28635045, PMID 29241771, PMID 29273100, PMID 29273101, PMID 29466675, PMID 29723356, PMID 29791718, PMID 30073292, PMID 30501016, PMID 31360041, PMID 31823902, PMID 32231700, PMID 32342443, PMID 32346854, PMID 32726554, PMID 33376289, PMID 33580923, PMID 33742252, PMID 33760691, PMID 35318791, PMID 35492401, PMID 35796224, PMID 36257912, PMID 7791384, PMID 8557859